Integumen receives orders from trio of global firms

Josh White Sharecast | 19 Jun, 2017 14:31 | | |

calculatrice-et-trombones-comptes-entrepreneurs-entreprises-argent-finances-tpe-pme-entreprenariat-finances-banques-startup-business-plan-argent

Integumen

2.72

17:19 23/10/17
0.00%
0.00
  • 36,534.39
  • -0.78%-287.84
  • Max: 36,960.93
  • Min: 36,534.39
  • Volume: 0
  • MM 200 : n/a
17:19 23/10/17

Human integumentary system-focussed personal healthcare company Integumen announced on Monday that it had received orders from La Prairie, Merck & Co., and Galderma.

The AIM-traded firm said it had first received orders from Swiss-based beauty company La Prairie, for Integumen to conduct efficacy trials using its ‘Labskin’ product as the platform, which would test certain materials in La Prairie's range of products.

Its board described Labskin as a “three-dimensional human skin equivalent” (HSE) model that resembled the discrete biological layers found in human skin.

Since the EU ban on testing of cosmetics on animals, the company believed it was “ideally positioned” to take advantage of the fact that HSEs were being increasingly used by developers operating in the dermatology space, such as La Prairie.

The second order, from international developer, manufacturer and distributor of pharmaceuticals Merck, was an evaluation order with Integumen - also for the company's Labskin HSE model.

Its third order announced on Monday was from dermatological treatment specialist Galderma, a subsidiary of Nestlé.

Galderma also ordered Labskin for the testing of materials and formulations in their headquarters in Lausanne, Switzerland.

“We are delighted to receive these orders from such reputable blue chip clients,” said Integumen CEO Declan Service.

“With an ever-increasing focus on the human microbiome, Labskin's advantage of being able to host bacteria in a similar environment to that of human skin is proving to be an attractive option for companies focussed on R&D in skincare.”

Service said that, while relatively small in revenue terms, the three orders both demonstrated the company’s ability to commercialise its products and technologies, and its ability to build relationships with established companies.

“In addition, we have secured our first order for Labskin under the three-year OEM supply agreement we signed with our partner in Germany, all of which is testament to the hard work our sales and marketing team continues to do.”

More news

17:23 London close: Stocks end little changed despite weak reading on industry

London stocks reversed an earlier small loss to trade slightly higher by the close of trading on Monday despite resilience in the pound against the greenback even after the release of weaker-than-expected data on industrial trends.

16:30 Tuesday preview: Results from Anglo American, Bunzl, St James's Place and Whitbread

Tuesday remains quiet for macroeconomic news but the week's major corporate results kick in with updates from Anglo American, Bunzl, St James's Place and Whitbread.

15:50 FTSE 250 movers: Spire surges as it rejects Mediclinic offer; IWG hit by downgrade

London’s FTSE 250 was down 0.2% to 20,109.57 in afternoon trade on Monday.

15:47 FTSE 100 movers: GKN rallies but Mediclinic drops as Spire rejects offer

London’s FTSE 100 was up 0.1% to 7,529.60 in afternoon trade on Monday.

15:33 US open: Stocks pause at record highs

Wall Street was trading on a mixed note in the early going on Monday, albeit after record closes during the previous session with sentiment underpinned by optimism over Trump’s tax plans as investors look ahead to more earnings releases.

15:04 Smith & Nephew acquires 'game changing' shoulder surgery technology

Smith & Nephew has agreed to snap up a US developer of a "game changing" surgical technology that helps speed the healing process in rotator cuff shoulder injuries.

15:11 FCA still investigating RBS's GRG over SME issues

The City watchdog has published an interim report into the treatment by Royal Bank of Scotland small business clients, though it said the bank remained under investigation over some unnamed matters that could see further regulatory action.

14:02 Asia report: Japan leads rise as Abe consolidates strength in election

Japanese equities led Asia-Pacific markets mostly higher on Monday as markets welcomed an election win for Shinzo Abe.

13:28 UK household pressures ease, rate hike expectations rise - IHS Markit

Financial pressures eased for UK households in October while rate hike expectations rose, according to the latest survey from IHS/Markit.

13:11 Europe midday: Stocks turn higher as German exporters balance Catalonia angst

European stocks were picking up a little steam after a listless Monday morning, as slippage in the euro benefitted exporters but Spain's issues with Catalonia continued to cause some anxiety.